| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $131.9M | +1.3% | +13.8% |
| Gross Profit | $91.3M | +1.7% | +15.5% |
| R&D Expense | $16.0M | -1.7% | -9.1% |
| SG&A Expense | $27.3M | -15.6% | +6.0% |
| Operating Income | $22.9M | +535.6% | +90.9% |
| Pre-tax Income | $18.9M | +1411.1% | +12.1% |
| Income Tax | -$248K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $315.6M | +43.8% | +15.1% |
| Accounts Receivable | $47.8M | -5.9% | -2.0% |
| Inventory | $20.3M | -18.8% | -0.2% |
| Current Assets | $449.2M | +8.3% | +25.9% |
| Total Assets | $1.37B | +1.8% | +7.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $83.7M | — | — |
| Capital Expenditures | $5.9M | — | — |
| Investing Cash Flow | -$3.8M | — | — |
| Financing Cash Flow | -$4.1M | — | — |
| Free Cash Flow | $77.8M | — | — |
| -111.1% |
| -114.6% |
| Net Income | $19.1M | +2052.8% | +26.3% |
| EPS (Basic) | $0.24 | +2500.0% | +20.0% |
| EPS (Diluted) | $0.24 | +2500.0% | +26.3% |
| $72.2M |
| -5.6% |
| +2.6% |
| Total Liabilities | $110.1M | -10.5% | +11.3% |
| Stockholders' Equity | $1.26B | +3.0% | +6.9% |